POIDOMANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 111
AS - Asia 40
EU - Europa 28
AF - Africa 13
SA - Sud America 6
Totale 198
Nazione #
US - Stati Uniti d'America 110
SG - Singapore 23
CN - Cina 12
IT - Italia 11
CI - Costa d'Avorio 9
IE - Irlanda 9
BR - Brasile 6
SN - Senegal 4
BE - Belgio 2
KR - Corea 2
RU - Federazione Russa 2
AT - Austria 1
CA - Canada 1
DE - Germania 1
GB - Regno Unito 1
IN - India 1
LK - Sri Lanka 1
TR - Turchia 1
UA - Ucraina 1
Totale 198
Città #
Santa Clara 30
Singapore 20
Houston 17
Abidjan 9
Dublin 9
Chicago 8
Chandler 7
Civitanova Marche 6
Boardman 5
Hefei 5
Catania 4
Dakar 4
Ashburn 3
Brussels 2
Seoul 2
Andover 1
Beijing 1
Boa Vista 1
Brasília 1
Cambridge 1
Colombo 1
Columbus 1
Concórdia 1
Florence 1
Galesburg 1
Guarapuava 1
Hopkins 1
Istanbul 1
Kingsville 1
Las Vegas 1
Lawrence 1
Los Angeles 1
Montes Claros 1
Mumbai 1
Munich 1
Ottawa 1
Phoenix 1
San Jose 1
Surubim 1
Tappahannock 1
The Dalles 1
Washington 1
Wilmington 1
Totale 159
Nome #
Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation 78
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 56
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 50
Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: Association with CD34+ mobilization and with disease-free survival 18
Totale 202
Categoria #
all - tutte 957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 1 0 0 0 0 0 1 0
2021/20225 0 1 0 0 1 0 1 0 1 0 0 1
2022/202335 3 0 1 2 6 4 2 10 2 0 3 2
2023/202434 3 9 1 1 3 7 0 3 0 1 5 1
2024/2025101 3 15 7 10 22 12 0 3 2 7 12 8
2025/20267 7 0 0 0 0 0 0 0 0 0 0 0
Totale 202